Singapore: ReproCELL, a Japanese stem cell technology company, has opened the company's first branch and US office in Bo...
Singapore: Scientists at The Scripps Research Institute (TSRI), US, have found a way to transform bone marrow stem cells...
Singapore: A new study by Reports and Reports predicted that the stem cell therapy market in Asia Pacific (APAC) will gr...
Singapore: Australia's Allied Healthcare's CardioCel tissue patches has shown superiority for stem cells survival and gr...
Development of stem cell therapies requires innovative technologies and processes to overcome safety concerns and VeriSt...
Sinapore: LifeMap Sciences, subsidiary of BioTime, has launched LifeMap Discovery, a roadmap of embryonic development an...
Blockbusters and super profits. Will the bioscience industry in this decade see these words come to life? More important...
Singapore: Adelaide-based biotechnology company Bionomics has strengthened its presence in the US with the acquisition o...
Singapore: A study conducted by Dr Steven Goldman and his team at the University of Rochester Medical Center (URMC), US,...
Singapore: Biokine Therapeutics received orphan drug designation from the US FDA for the mobilization of hematopoietic s...
Singapore: Swedish doctors have for the first time in history been able to pair the groin vein of a dead donor with stem...
Singapore: Osiris Therapeutics, a Columbia-based company focused on developing and marketing stem cell products to treat...
Singapore: Australian regenerative medicine firm, Orthocell, is looking ahead to raise $8 million through an Initial Pub...
Singapore: Cytori Therapeutics announced that a 40-patient, multi-center investigator-sponsored and funded clinical stu...
Singapore: Australian regenerative drug company, Mesoblast, is planning to expand its global manufacturing base and the ...
Singapore: Korean scientists have developed a breakthrough technology that can more efficiently and safely reprogram adu...
Singapore: A research team at the tissue regeneration materials unit, National Institute for Materials Science (NIMS), s...
Singapore: Australia's Genea Stem Cells, a supplier and developer of disease-specific human stem cells, has been success...
